Cite
HARVARD Citation
Lonetti, A. et al. (2016). Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway. Journal of hematology & oncology. 9 (1), pp. 1-16. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lonetti, A. et al. (2016). Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway. Journal of hematology & oncology. 9 (1), pp. 1-16. [Online].